Elena V. Fefelova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena V. Fefelova has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Namzhil N. Tsybikov
Chita State Medical Academy
15 shared publications - Pavel P. Tereshkov
Chita State Medical Academy
14 shared publications - Tatyana M. Karavaeva
Chita State Medical Academy
6 shared publications - Irina V. Kibalina
Chita State Medical Academy
5 shared publications - Maria V. Maksimenya
Chita State Medical Academy
5 shared publications - A. Yu. Ma-Van-De
Chita State Medical Academy
4 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 123-132
Current Concepts of the Pathogenesis of Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is characterized by impaired motility at the gastroesophageal junction and the development of inflammatory changes in the mucosa of the distal esophagus. The aim of this review is to discuss the mechanisms contributing to the development of GERD. A literature search was conducted using the eLibrary.Ru and PubMed databases, focusing on articles published after 2000. Following the application of selection criteria, a total of 80 articles were included in the final literature review. Current understanding suggests that reflux esophagitis begins with damage to the esophageal epithelium caused by the reflux of acid and pepsin, leading to increased epithelial permeability. This allows hydrochloric acid and pepsin to penetrate deeper into the epithelial layer, attacking intact cells. Research indicates that the mechanisms of epithelial damage in the esophagus induced by acidic and bile reflux differ. Acid reflux causes tissue damage through protein denaturation, degradation by proteases, activation of cyclooxygenase-2 (COX-2), c-myc, and mitogen-activated protein kinase pathways, while simultaneously limiting prostaglandin synthesis. In contrast, bile acids induce cytotoxic mechanisms, activating oncogenes and c-myc, which contribute to epigenetic carcinogenic processes. Alterations in the esophageal microbiome trigger the activation of both innate and adaptive immune systems, as well as the sensory nervous system. Immune competent cells express receptors for numerous mediators released by sensory and autonomic nerves, enabling the nervous system to directly regulate the functional activity of the immune system. Conversely, immune cells can produce neuroactive substances and modulate nervous system functions, including pacemaker cells, leading to the development of reflux and exposing the esophageal mucosa to hydrochloric acid and pepsin or bile acids, resulting in inflammation and creating a vicious cycle.
- 2 August 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 9,p. 123-132
Open AccessCurrent Concepts of the Pathogenesis of Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is characterized by impaired motility at the gastroesophageal junction and the development of inflammatory changes in the mucosa of the distal esophagus. The aim of this review is to discuss the mechanisms contributing to the development of GERD. A literature search was conducted using the eLibrary.Ru and PubMed databases, focusing on articles published after 2000. Following the application of selection criteria, a total of 80 articles were included in the final literature review. Current understanding suggests that reflux esophagitis begins with damage to the esophageal epithelium caused by the reflux of acid and pepsin, leading to increased epithelial permeability. This allows hydrochloric acid and pepsin to penetrate deeper into the epithelial layer, attacking intact cells. Research indicates that the mechanisms of epithelial damage in the esophagus induced by acidic and bile reflux differ. Acid reflux causes tissue damage through protein denaturation, degradation by proteases, activation of cyclooxygenase-2 (COX-2), c-myc, and mitogen-activated protein kinase pathways, while simultaneously limiting prostaglandin synthesis. In contrast, bile acids induce cytotoxic mechanisms, activating oncogenes and c-myc, which contribute to epigenetic carcinogenic processes. Alterations in the esophageal microbiome trigger the activation of both innate and adaptive immune systems, as well as the sensory nervous system. Immune competent cells express receptors for numerous mediators released by sensory and autonomic nerves, enabling the nervous system to directly regulate the functional activity of the immune system. Conversely, immune cells can produce neuroactive substances and modulate nervous system functions, including pacemaker cells, leading to the development of reflux and exposing the esophageal mucosa to hydrochloric acid and pepsin or bile acids, resulting in inflammation and creating a vicious cycle.
- Open Access
- 30 July 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 2,p. 118-131
THE ROLE OF TRYPTOPHAN METABOLISM DYSREGULATION IN THE INITIATION AND PROGRESSION OF MALIGNANT NEOPLASMS
Aim. To summarize current data on tryptophan catabolism and the pathophysiological mechanisms involving tryptophan, its enzymes, and metabolites in tumor initiation and progression. Materials and methods. A comprehensive search for scientific articles published between 2020 and 2026 was conducted using PubMed, eLIBRARY, and Google Scholar databases. The search used keywords in both Russian and English: «tryptophan metabolism», «kynurenine pathway», «serotonin pathway», «indole pathway», «IDO1», «TDO2», «immunosuppression», «carcinogenesis», «cancer». Inclusion criteria: publications containing data on metabolic, molecular and cellular mechanisms of tryptophan and its metabolites in cancer initiation and progression, as well as clinical studies evaluating the predictive and prognostic value of these substances in oncology. Exclusion criteria: articles in languages other than english and russian, reports, study protocols, duplicates and studies with incomplete data.A total of 37 sources were analyzed, including 3 russian publications, all published within the last 5 years. Results. Tryptophan metabolic reprogramming is recognized as a hallmark biochemical feature of tumor cells. This review synthesizes current findings on the catabolic pathways of this amino acid and the mechanisms by which tryptophan and its metabolites contribute to the initiation and progression of malignant neoplasms. Particular emphasis is placed on the hyperactivation of the kynurenine pathway mediated by the enzymes IDO1 and TDO2, which leads to immunosuppression, chronic inflammation, and the stimulation of metastasis. Furthermore, the dysregulation of the serotonin and indole pathways and their subsequent impact on carcinogenesis and progression are addressed. Conclusion. The literature analysis highlights the critical pathogenetic role of tryptophan metabolism disorders in tumor progression and immune evasion. Investigating the enzymatic components of the kynurenine cascade provides a strong rationale for developing novel therapeutic strategies aimed at inhibiting IDO1 and TDO2 activity in oncological practice.
- 30 July 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 2,p. 118-131
Open AccessTHE ROLE OF TRYPTOPHAN METABOLISM DYSREGULATION IN THE INITIATION AND PROGRESSION OF MALIGNANT NEOPLASMS
Aim. To summarize current data on tryptophan catabolism and the pathophysiological mechanisms involving tryptophan, its enzymes, and metabolites in tumor initiation and progression. Materials and methods. A comprehensive search for scientific articles published between 2020 and 2026 was conducted using PubMed, eLIBRARY, and Google Scholar databases. The search used keywords in both Russian and English: «tryptophan metabolism», «kynurenine pathway», «serotonin pathway», «indole pathway», «IDO1», «TDO2», «immunosuppression», «carcinogenesis», «cancer». Inclusion criteria: publications containing data on metabolic, molecular and cellular mechanisms of tryptophan and its metabolites in cancer initiation and progression, as well as clinical studies evaluating the predictive and prognostic value of these substances in oncology. Exclusion criteria: articles in languages other than english and russian, reports, study protocols, duplicates and studies with incomplete data.A total of 37 sources were analyzed, including 3 russian publications, all published within the last 5 years. Results. Tryptophan metabolic reprogramming is recognized as a hallmark biochemical feature of tumor cells. This review synthesizes current findings on the catabolic pathways of this amino acid and the mechanisms by which tryptophan and its metabolites contribute to the initiation and progression of malignant neoplasms. Particular emphasis is placed on the hyperactivation of the kynurenine pathway mediated by the enzymes IDO1 and TDO2, which leads to immunosuppression, chronic inflammation, and the stimulation of metastasis. Furthermore, the dysregulation of the serotonin and indole pathways and their subsequent impact on carcinogenesis and progression are addressed. Conclusion. The literature analysis highlights the critical pathogenetic role of tryptophan metabolism disorders in tumor progression and immune evasion. Investigating the enzymatic components of the kynurenine cascade provides a strong rationale for developing novel therapeutic strategies aimed at inhibiting IDO1 and TDO2 activity in oncological practice.
- 27 May 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (2) , 118-128
Indicators of the innate immune system in patients with severe COVID-19 and their role in the development of coagulopathy
SARS-CoV-2 is one of the few viruses that cause blood coagulation disorders. The pathogenesis of coagulopathies in COVID-19 is polyetiological: cytokine storm, NETosis, dysfunction of the renin-angiotensin system, thrombotic microangiopathy, disseminated intravascular coagulation (DIC), and hypofibrinolysis. However, the role of the immune system in the development of these disorders remains insufficiently described. The aim . To characterize the role of the innate immune system in the development of coagulopathies in patients with severe COVID-19. Methods . The study included a cohort of 103 patients with severe COVID-19 receiving anticoagulant therapy and undergoing treatment in Chita, Russia. Hemostasis was assessed using thrombodynamics testing, as well as measurement of fibrinogen, D-dimer, tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1). All patients with SARS-CoV-2 were stratified into four subgroups based on their hemostatic status. Levels of tissue factor (TF), D-dimer, tPA, PAI-1, myeloperoxidase (MPO), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and cystatin C were determined by flow cytometry. Results . In the pronounced hypercoagulation and hypercoagulation groups, elevated fibrinogen levels were observed, along with a parallel increase in tPA concentration and a sharp rise in PAI-1 levels. Meanwhile, maximal TF-values were recorded in patients with hypocoagulation. MMP-2 levels were lower than those in the control group in all COVID-19 patients, but progressively increased from normocoagulation to hypocoagulation, reaching a maximum in the latter group. MMP-9 and MPO concentrations were elevated across all groups, peaking in the normocoagulation group. Cystatin C concentration was increased in all patients. Conclusion . Severe COVID-19 is associated with the development of thrombotic coagulopathy, driven by the formation of a vicious cycle of “thromboinflammation,” in which hemostatic disorders and systemic inflammatory response mutually reinforce each other.
- 27 May 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (2) , 118-128
Indicators of the innate immune system in patients with severe COVID-19 and their role in the development of coagulopathy
SARS-CoV-2 is one of the few viruses that cause blood coagulation disorders. The pathogenesis of coagulopathies in COVID-19 is polyetiological: cytokine storm, NETosis, dysfunction of the renin-angiotensin system, thrombotic microangiopathy, disseminated intravascular coagulation (DIC), and hypofibrinolysis. However, the role of the immune system in the development of these disorders remains insufficiently described. The aim . To characterize the role of the innate immune system in the development of coagulopathies in patients with severe COVID-19. Methods . The study included a cohort of 103 patients with severe COVID-19 receiving anticoagulant therapy and undergoing treatment in Chita, Russia. Hemostasis was assessed using thrombodynamics testing, as well as measurement of fibrinogen, D-dimer, tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1). All patients with SARS-CoV-2 were stratified into four subgroups based on their hemostatic status. Levels of tissue factor (TF), D-dimer, tPA, PAI-1, myeloperoxidase (MPO), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and cystatin C were determined by flow cytometry. Results . In the pronounced hypercoagulation and hypercoagulation groups, elevated fibrinogen levels were observed, along with a parallel increase in tPA concentration and a sharp rise in PAI-1 levels. Meanwhile, maximal TF-values were recorded in patients with hypocoagulation. MMP-2 levels were lower than those in the control group in all COVID-19 patients, but progressively increased from normocoagulation to hypocoagulation, reaching a maximum in the latter group. MMP-9 and MPO concentrations were elevated across all groups, peaking in the normocoagulation group. Cystatin C concentration was increased in all patients. Conclusion . Severe COVID-19 is associated with the development of thrombotic coagulopathy, driven by the formation of a vicious cycle of “thromboinflammation,” in which hemostatic disorders and systemic inflammatory response mutually reinforce each other.
- 19 May 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 77-90
Subpopulation and functional activity of regulatory T-lymphocytes in patients with chronic polyposis rhinosinusitis
Overcoming therapeutic resistance in chronic polypous rhinosinusitis (CRS) is directly linked to the recognition of its immunological heterogeneity. The modern paradigm views CRS as a spectrum of distinct endotypes (Th1, Th2, Th17), each requiring a specific targeted approach, making detailed immune profiling the cornerstone of personalized treatment strategies. Objective. To study the numerical composition and functional activity of T-regulatory lymphocytes at different stages of differentiation depending on the immune response type in patients with chronic polypous rhinosinusitis. Materials and Methods. The study included 44 patients suffering from chronic polypous rhinosinusitis. The control group consisted of 20 patients without chronic rhinosinusitis and concomitant pathology who underwent septoplasty. Using cluster analysis (k-means), all patients were divided into three clusters: 1 st – patients with T helper 1 type immune response, 2 nd – T helper 2 type, 3 rd – T helper 17 type immune response. The content of Treg cells with the CD4+CD25hiCD127low phenotype in the venous blood of the subjects and the levels of cytokines (IL-2, IL-6, IL-10, TGF-β1, TNF-α) in blood serum and tissue homogenates were studied using the multiplex analysis system "Human Essential Immune Response Panel" by Biolegend (USA). Results. The total number of Treg was increased in Th-2 and Th-1 immune responses, while it was minimal in the Th-17 response. The pool of naive Treg was preserved only in the Th-2 immune response. A progressive decrease in memory Treg was observed from the Th-1/Th-2 to the Th-17 response. Systemic disturbances in cytokine balance have been identified, explaining various mechanisms of pathogenesis of nasal polyps formation with different types of immune response. Conclusion. Differences in the state of the immune regulatory system were established in patients with various immune endotypes of chronic polypous rhinosinusitis, manifested both at the level of cellular composition and the functional activity of T regulatory lymphocytes, which have a divergent nature depending on the CRS immune endotype. The concordance of changes in the cellular and cytokine profiles in peripheral blood and polyp tissue confirms the systemic nature of immunopathological disorders in CRS.
- 19 May 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 77-90
Subpopulation and functional activity of regulatory T-lymphocytes in patients with chronic polyposis rhinosinusitis
Overcoming therapeutic resistance in chronic polypous rhinosinusitis (CRS) is directly linked to the recognition of its immunological heterogeneity. The modern paradigm views CRS as a spectrum of distinct endotypes (Th1, Th2, Th17), each requiring a specific targeted approach, making detailed immune profiling the cornerstone of personalized treatment strategies. Objective. To study the numerical composition and functional activity of T-regulatory lymphocytes at different stages of differentiation depending on the immune response type in patients with chronic polypous rhinosinusitis. Materials and Methods. The study included 44 patients suffering from chronic polypous rhinosinusitis. The control group consisted of 20 patients without chronic rhinosinusitis and concomitant pathology who underwent septoplasty. Using cluster analysis (k-means), all patients were divided into three clusters: 1 st – patients with T helper 1 type immune response, 2 nd – T helper 2 type, 3 rd – T helper 17 type immune response. The content of Treg cells with the CD4+CD25hiCD127low phenotype in the venous blood of the subjects and the levels of cytokines (IL-2, IL-6, IL-10, TGF-β1, TNF-α) in blood serum and tissue homogenates were studied using the multiplex analysis system "Human Essential Immune Response Panel" by Biolegend (USA). Results. The total number of Treg was increased in Th-2 and Th-1 immune responses, while it was minimal in the Th-17 response. The pool of naive Treg was preserved only in the Th-2 immune response. A progressive decrease in memory Treg was observed from the Th-1/Th-2 to the Th-17 response. Systemic disturbances in cytokine balance have been identified, explaining various mechanisms of pathogenesis of nasal polyps formation with different types of immune response. Conclusion. Differences in the state of the immune regulatory system were established in patients with various immune endotypes of chronic polypous rhinosinusitis, manifested both at the level of cellular composition and the functional activity of T regulatory lymphocytes, which have a divergent nature depending on the CRS immune endotype. The concordance of changes in the cellular and cytokine profiles in peripheral blood and polyp tissue confirms the systemic nature of immunopathological disorders in CRS.
- Open Access
- 22 March 2026
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 11 (1) , 15-24
Morphological and immunological features of chronic polypous rhinosinusitis depending on the presence of comorbid background
Chronic rhinosinusitis is a heterogeneous and multifactorial inflammatory disease of the nasal mucosa and paranasal sinuses. Aim. To evaluate the morphological and some immunological features of nasal polyps in individuals suffering from chronic rhinosinusitis with various comorbid backgrounds. Materials and methods. The study included 76 patients with chronic polypous rhinosinusitis and comorbidities such as bronchial asthma(, hypertension, chronic obstructive pulmonary disease (COPD). The control group consisted of patients without chronic rhinosinusitis or associated comorbidities, operated on for septoplasty. We analyzed the quantitative and qualitative cellular composition of polyp biopsies and mucosal samples from the control group. The concentration of cytokines (IL- 8, IP-10, MCP-1) was determined in blood serum and tissue homogenates using the multiplex analysis system "Human Essential Immune Response Panel" by BioLegend (USA). Results. The total number of cells per 1 mm2 in polyp tissue was maximum in patients with a history of bronchial asthma and hypertension. In individuals with bronchial asthma, eosinophils and neutrophils prevailed in polyp preparations. In patients with hypertension and without comorbid conditions, lymphocytes prevailed. Biopsy specimens of nasal polyps in patients with COPD had approximately the same number of eosinophils and lymphocytes, with the maximum number of plasma cells. The concentration of IP-10 did not differ significantly in blood serum and tissue homogenate and was maximum in individuals with bronchial asthma. The maximum concentration of IL-8 was recorded in patients with bronchial asthma, and in tissues - in individuals with hypertension. The highest concentration of MCP-1 in both blood serum and polyp tissue homogenates was found in patients with bronchial asthma. Conclusions. The induction of polyp formation and their cellular composition are influenced by the patient’s comorbid background.
- 22 March 2026
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 11 (1) , 15-24
Open AccessMorphological and immunological features of chronic polypous rhinosinusitis depending on the presence of comorbid background
Chronic rhinosinusitis is a heterogeneous and multifactorial inflammatory disease of the nasal mucosa and paranasal sinuses. Aim. To evaluate the morphological and some immunological features of nasal polyps in individuals suffering from chronic rhinosinusitis with various comorbid backgrounds. Materials and methods. The study included 76 patients with chronic polypous rhinosinusitis and comorbidities such as bronchial asthma(, hypertension, chronic obstructive pulmonary disease (COPD). The control group consisted of patients without chronic rhinosinusitis or associated comorbidities, operated on for septoplasty. We analyzed the quantitative and qualitative cellular composition of polyp biopsies and mucosal samples from the control group. The concentration of cytokines (IL- 8, IP-10, MCP-1) was determined in blood serum and tissue homogenates using the multiplex analysis system "Human Essential Immune Response Panel" by BioLegend (USA). Results. The total number of cells per 1 mm2 in polyp tissue was maximum in patients with a history of bronchial asthma and hypertension. In individuals with bronchial asthma, eosinophils and neutrophils prevailed in polyp preparations. In patients with hypertension and without comorbid conditions, lymphocytes prevailed. Biopsy specimens of nasal polyps in patients with COPD had approximately the same number of eosinophils and lymphocytes, with the maximum number of plasma cells. The concentration of IP-10 did not differ significantly in blood serum and tissue homogenate and was maximum in individuals with bronchial asthma. The maximum concentration of IL-8 was recorded in patients with bronchial asthma, and in tissues - in individuals with hypertension. The highest concentration of MCP-1 in both blood serum and polyp tissue homogenates was found in patients with bronchial asthma. Conclusions. The induction of polyp formation and their cellular composition are influenced by the patient’s comorbid background.
- Open Access
- 2 November 2025
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 3,p. 3-12
SERUM LEVEL OF SOLUBLE MOLECULES OF IMMUNE RESPONSE CHECKPOINTS IN PATIENTS WITH VARIOUS FORMS OF AUTOIMMUNE THYROIDITIS
Introduction : The prevalence of chronic autoimmune thyroiditis (AIT) is more than 5% of the world's population. Despite this, the tactics and methods of treating AIT have not undergone innovations in terms of therapy for many years, while the modern trend in the treatment of other autopathologies is to use monoclonal antibodies. However, it was noted that with the use of some immune checkpoint inhibitors for the treatment of oncopathology, various autoimmune diseases debuted in patients. This fact opens up the prospect of studying new links in the pathogenesis of AIT. Aim : determination of the level of sCD25, s4-1BB, sTim-3, sLAG-3, sGalectin-9 molecules in individuals suffering from various forms of AIT. Material and methods : The study involved 31 subjects aged 18 to 40 years, divided into four groups: I Healthy (n = 10); II Carriers of antibodies to thyroid peroxidase (ATkTPO) (n = 11); III Subclinical form of hypothyroidism AIT (n = 6); IV AIT with hypothyroidism, medically compensated (n = 4). Venous blood was collected to determine the ATkTPO level by ELISA, the concentration of thyroid-stimulating hormone and free thyroxine by immunochemiluminescence, the level of CD25, 4-1BB, Tim-3, LAG-3, Galectin-9 by flow cytofluorimetry. Statistical processing was performed using the Kruskal-Wallis one-way analysis of variance. Results: The sCD25 level decreased by almost 85% (P = 0,001) from the control 19,2 pg/ml (2,20; 29,9) in groups: II 2.83 pg/ml (2,24; 3,17), III 3,23 pg/ml (2,69; 45,8), and IV 3,05 pg/ml (2,31; 7,37). The concentration of 4-1BB increased threefold (P = 0,001) in groups: II 35,0 pg/ml (15,5; 39,8), III 31,9 (27,8; 44,4) from the control 11,8 pg/ml (4,96; 14,0). sTim-3 decreased by more than 98% (P = 0,001) from group I 280 pg/ml (13,7; 321) when compared with groups: II 5,22 pg/ml (2,13; 6,34), III 4,10 pg/ml (3,36; 5,34), IV 1,26 pg/ml (0,362; 2,45). The content of LAG-3 decreased by 66% (P = 0,001) when comparing group, I 51,1 pg/ml (20,1; 60,1) with II 20,1 pg/ml (2,23; 41,6). The concentration of Galectin-9 in group II 277 pg/ml (196; 378) is 5 times lower than in I 1377 pg/ml (1140; 1910) (P = 0,001). Conclusion : With the development of AIT, the concentration of CD25, Tim-3, LAG-3, Galectin-9 decreases, and the level of 4-1BB increases.
- 2 November 2025
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 3,p. 3-12
Open AccessSERUM LEVEL OF SOLUBLE MOLECULES OF IMMUNE RESPONSE CHECKPOINTS IN PATIENTS WITH VARIOUS FORMS OF AUTOIMMUNE THYROIDITIS
Introduction : The prevalence of chronic autoimmune thyroiditis (AIT) is more than 5% of the world's population. Despite this, the tactics and methods of treating AIT have not undergone innovations in terms of therapy for many years, while the modern trend in the treatment of other autopathologies is to use monoclonal antibodies. However, it was noted that with the use of some immune checkpoint inhibitors for the treatment of oncopathology, various autoimmune diseases debuted in patients. This fact opens up the prospect of studying new links in the pathogenesis of AIT. Aim : determination of the level of sCD25, s4-1BB, sTim-3, sLAG-3, sGalectin-9 molecules in individuals suffering from various forms of AIT. Material and methods : The study involved 31 subjects aged 18 to 40 years, divided into four groups: I Healthy (n = 10); II Carriers of antibodies to thyroid peroxidase (ATkTPO) (n = 11); III Subclinical form of hypothyroidism AIT (n = 6); IV AIT with hypothyroidism, medically compensated (n = 4). Venous blood was collected to determine the ATkTPO level by ELISA, the concentration of thyroid-stimulating hormone and free thyroxine by immunochemiluminescence, the level of CD25, 4-1BB, Tim-3, LAG-3, Galectin-9 by flow cytofluorimetry. Statistical processing was performed using the Kruskal-Wallis one-way analysis of variance. Results: The sCD25 level decreased by almost 85% (P = 0,001) from the control 19,2 pg/ml (2,20; 29,9) in groups: II 2.83 pg/ml (2,24; 3,17), III 3,23 pg/ml (2,69; 45,8), and IV 3,05 pg/ml (2,31; 7,37). The concentration of 4-1BB increased threefold (P = 0,001) in groups: II 35,0 pg/ml (15,5; 39,8), III 31,9 (27,8; 44,4) from the control 11,8 pg/ml (4,96; 14,0). sTim-3 decreased by more than 98% (P = 0,001) from group I 280 pg/ml (13,7; 321) when compared with groups: II 5,22 pg/ml (2,13; 6,34), III 4,10 pg/ml (3,36; 5,34), IV 1,26 pg/ml (0,362; 2,45). The content of LAG-3 decreased by 66% (P = 0,001) when comparing group, I 51,1 pg/ml (20,1; 60,1) with II 20,1 pg/ml (2,23; 41,6). The concentration of Galectin-9 in group II 277 pg/ml (196; 378) is 5 times lower than in I 1377 pg/ml (1140; 1910) (P = 0,001). Conclusion : With the development of AIT, the concentration of CD25, Tim-3, LAG-3, Galectin-9 decreases, and the level of 4-1BB increases.
- 30 September 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (3) , 377-386
Changes in the amount of matrix metalloproteinases and kynurenines in individuals with diabetic retinopathy, their role in the development of the disease
INTRODUCTION: Diabetic retinopathy (DR) is one of most common chronic complications of diabetes mellitus (DM). The pathogenesis of DR is complex and involves interaction of many molecular mechanisms, and far not all of them have been studied. AIM: To determine the level of matrix metalloproteinases and kynurenines in the blood of patients with type 2 DM (T2DM) with different stages of DR. MATERIALS AND METHODS: Four groups of patients were formed: Group 1 (control) — 21 healthy individuals; Group 2 — 21 patients with prediabetes, Group 3 — 21 patients with T2DM, Group 4 — 63 patients with T2DM and DR. Then patients with DR were divided into groups (n = 21): Group 5 — non-proliferative stage of DR, Group 6 — preproliferative DR, Group 7 — proliferative DR. In the blood serum, the following parameters were determined: the content of metalloproteinases (MMP) types 2 and 9 (MMP-2, MMP-9) by the enzyme immunoassay; in blood plasma — the concentration of kynurenines by the high-performance liquid chromatography. RESULTS: Significant differences were recorded in the studied parameters between healthy individuals and patients with diabetes. Subsequently, the results of patients with different stages of DR were compared with the data of patients with diabetes without vascular complications. In the preproliferative stage of DR, an excess of blood MMP-2 by 87.9% (p = 0.030) and MMP-9 by 37% (p = 0.049) was recorded relative to the individuals with diabetes. In the proliferative stage of DR, the levels of MMP-9 and MMP-2 were higher than those of not only the comparison group, but also the groups of non-proliferative and preproliferative stages of DR. In the preproliferative stage of DR, an increased concentration of 3-hydroxykynurenine was also recorded. The maximum increase in kynurenines was noted in the final stage of DR (p 0.05 relative to the groups of non-proliferative and preproliferative DR). CONCLUSIONS: In the analyzed groups of individuals, the concentrations of kynurenines increased as the underlying disease progressed. The level of MMP-9 was higher in diabetes mellitus, and in the proliferative stage of DR, the values of MMP-9 and MMP-2 increased.
- 30 September 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (3) , 377-386
Changes in the amount of matrix metalloproteinases and kynurenines in individuals with diabetic retinopathy, their role in the development of the disease
INTRODUCTION: Diabetic retinopathy (DR) is one of most common chronic complications of diabetes mellitus (DM). The pathogenesis of DR is complex and involves interaction of many molecular mechanisms, and far not all of them have been studied. AIM: To determine the level of matrix metalloproteinases and kynurenines in the blood of patients with type 2 DM (T2DM) with different stages of DR. MATERIALS AND METHODS: Four groups of patients were formed: Group 1 (control) — 21 healthy individuals; Group 2 — 21 patients with prediabetes, Group 3 — 21 patients with T2DM, Group 4 — 63 patients with T2DM and DR. Then patients with DR were divided into groups (n = 21): Group 5 — non-proliferative stage of DR, Group 6 — preproliferative DR, Group 7 — proliferative DR. In the blood serum, the following parameters were determined: the content of metalloproteinases (MMP) types 2 and 9 (MMP-2, MMP-9) by the enzyme immunoassay; in blood plasma — the concentration of kynurenines by the high-performance liquid chromatography. RESULTS: Significant differences were recorded in the studied parameters between healthy individuals and patients with diabetes. Subsequently, the results of patients with different stages of DR were compared with the data of patients with diabetes without vascular complications. In the preproliferative stage of DR, an excess of blood MMP-2 by 87.9% (p = 0.030) and MMP-9 by 37% (p = 0.049) was recorded relative to the individuals with diabetes. In the proliferative stage of DR, the levels of MMP-9 and MMP-2 were higher than those of not only the comparison group, but also the groups of non-proliferative and preproliferative stages of DR. In the preproliferative stage of DR, an increased concentration of 3-hydroxykynurenine was also recorded. The maximum increase in kynurenines was noted in the final stage of DR (p 0.05 relative to the groups of non-proliferative and preproliferative DR). CONCLUSIONS: In the analyzed groups of individuals, the concentrations of kynurenines increased as the underlying disease progressed. The level of MMP-9 was higher in diabetes mellitus, and in the proliferative stage of DR, the values of MMP-9 and MMP-2 increased.
- Open Access
- 31 August 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (4) , 161-175
NEURAL NETWORK ANALYSIS AS A WAY TO ASSESS SOME PATHOGENETIC ASPECTS OF NEUROINFLAMMATION IN HYPERTENSIVE DISEASE
Highlights Cardiovascular diseases are the leading cause of death in the population. The most common cardiovascular disease is hypertension, which can lead to damage to target organs, including the brain. Several studies have examined the role of specific neuroinflammatory molecules and tumor necrosis factor family proteins in the progression and outcome of vascular-related cerebral damage. The article highlights the possibilities of neural network analysis, which can be used to determine the ranked contribution of certain biomarkers to the pathogenesis of neuroinflammation that develops in hypertension. AbstractBackground. Hypertensive disease is accompanied by involvement of target organs, including the brain, in the pathological process, leading to the development of acute and chronic cerebrovascular diseases. The development of modern methods for predicting the development and course of angio-cerebral pathology can be used to create new methods for managing patients at risk.Aim. Using the capabilities of neural network analysis, we determined the ranked contribution of biomarkers of neuroinflammation and proteins of the tumor necrosis factor family to the pathogenesis of neuroinflammation in the context of hypertension.Methods. The study involved 80 participants. The control group consisted of healthy individuals. The first group included patients with stage II–III hypertension, achieved target blood pressure levels, and a 3–4 risk of developing cardiovascular complications. The second group consisted of patients with stage II–III hypertension, unachieved target blood pressure levels, and a 3–4 risk of developing cardiovascular complications. Group 3 included patients with a verified diagnosis of ischemic (atherothrombotic) stroke. The data obtained from the study were used to train a multilayer perceptron and create a mathematical model that determines the ranked contribution of biomarkers of neuroinflammation and proteins of the tumor necrosis factor family to the pathogenesis of neuroinflammation in the context of hypertension.Results. According to the results of the conducted multiplex analysis and statistical data processing, similar shifts in the neuroimmune status were identified in both patients with ischemic stroke and individuals with hypertension. Modern developments in the field of predicting the development and course of angiocerebral pathology can be used to create new methods for managing patients at risk.Conclusion. The data obtained as a result of the conducted study indicate changes in the neuroimmune status of patients with hypertension. It is noteworthy that the content of biomarkers associated with neuroinflammation in patients with unattained target blood pressure levels is as close as possible to that of patients with ischemic stroke. At the same time, in the group of patients with achieved target blood pressure levels, there is also a shift in the studied indicators, but to a lesser extent, which may indicate the presence of a neuroinflammatory process that is present even in the presence of antihypertensive therapy and blood pressure control. The mathematical model developed using neural network analysis allowed us to determine the ranked contribution of the studied parameters to the pathogenesis of neuroinflammation in patients with hypertension. These results can be further used for a more personalized approach to patient treatment by influencing specific aspects of the pathogenesis, thereby moderating the ongoing process and influencing the future course of the disease.
- 31 August 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (4) , 161-175
Open AccessNEURAL NETWORK ANALYSIS AS A WAY TO ASSESS SOME PATHOGENETIC ASPECTS OF NEUROINFLAMMATION IN HYPERTENSIVE DISEASE
Highlights Cardiovascular diseases are the leading cause of death in the population. The most common cardiovascular disease is hypertension, which can lead to damage to target organs, including the brain. Several studies have examined the role of specific neuroinflammatory molecules and tumor necrosis factor family proteins in the progression and outcome of vascular-related cerebral damage. The article highlights the possibilities of neural network analysis, which can be used to determine the ranked contribution of certain biomarkers to the pathogenesis of neuroinflammation that develops in hypertension. AbstractBackground. Hypertensive disease is accompanied by involvement of target organs, including the brain, in the pathological process, leading to the development of acute and chronic cerebrovascular diseases. The development of modern methods for predicting the development and course of angio-cerebral pathology can be used to create new methods for managing patients at risk.Aim. Using the capabilities of neural network analysis, we determined the ranked contribution of biomarkers of neuroinflammation and proteins of the tumor necrosis factor family to the pathogenesis of neuroinflammation in the context of hypertension.Methods. The study involved 80 participants. The control group consisted of healthy individuals. The first group included patients with stage II–III hypertension, achieved target blood pressure levels, and a 3–4 risk of developing cardiovascular complications. The second group consisted of patients with stage II–III hypertension, unachieved target blood pressure levels, and a 3–4 risk of developing cardiovascular complications. Group 3 included patients with a verified diagnosis of ischemic (atherothrombotic) stroke. The data obtained from the study were used to train a multilayer perceptron and create a mathematical model that determines the ranked contribution of biomarkers of neuroinflammation and proteins of the tumor necrosis factor family to the pathogenesis of neuroinflammation in the context of hypertension.Results. According to the results of the conducted multiplex analysis and statistical data processing, similar shifts in the neuroimmune status were identified in both patients with ischemic stroke and individuals with hypertension. Modern developments in the field of predicting the development and course of angiocerebral pathology can be used to create new methods for managing patients at risk.Conclusion. The data obtained as a result of the conducted study indicate changes in the neuroimmune status of patients with hypertension. It is noteworthy that the content of biomarkers associated with neuroinflammation in patients with unattained target blood pressure levels is as close as possible to that of patients with ischemic stroke. At the same time, in the group of patients with achieved target blood pressure levels, there is also a shift in the studied indicators, but to a lesser extent, which may indicate the presence of a neuroinflammatory process that is present even in the presence of antihypertensive therapy and blood pressure control. The mathematical model developed using neural network analysis allowed us to determine the ranked contribution of the studied parameters to the pathogenesis of neuroinflammation in patients with hypertension. These results can be further used for a more personalized approach to patient treatment by influencing specific aspects of the pathogenesis, thereby moderating the ongoing process and influencing the future course of the disease.
- Open Access
- 8 May 2025
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 72-79
Dynamics of concentration of neuroinflammatory molecules in ischemic stroke
The aim of the research. To determine the level of transforming growth factor-β (TGF-β), brain-derived neurotrophic factor (BDNF) and nerve growth factor (β-NGF) in the blood serum of patients with ischemic stroke (atherothrombotic subtype) in the acute period and over time.Materials and methods. The study involved 60 people (50% men and 50% women), who were divided into three groups of 20 people. Group I – healthy individuals; Group II – patients with hypertensive crisis without signs of target organ damage (uncomplicated hypertensive crisis); III – patients with a verified diagnosis of atherothrombotic ischemic stroke that developed against the background of a hypertensive crisis. Patients of groups I, II and III were comparable by gender, age, II and III also by comorbid background. The average age of patients was 56,3 (48,8; 63,3) years.Results. Based on the results of the study, it was found that in individuals with uncomplicated hypertensive crisis, as well as in patients with ischemic stroke, an increase in the concentration of BDNF and β-NGF in the blood serum was recorded on the first day. TGF-β1 indicators changed only in patients with ischemic stroke. In the group of patients with ischemic stroke, an increase in BDNF, β-NGF, TGF-β1 indicators was observed from the first day from the onset of the disease and persisted throughout the study period. Positive correlations were found between the concentration of BDNF and systolic and diastolic blood pressure (BP), as well as between the concentration of β-NGF and the number of points on the NIHSS scale, SBP and DBP levels.Conclusion. The registered increase in the concentration of BDNF, β-NGF in patients with hypertensive crisis may indicate the activation of microglia due to damage to the brain as a target organ, even in the absence of neurological symptoms.
- 8 May 2025
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 72-79
Open AccessDynamics of concentration of neuroinflammatory molecules in ischemic stroke
The aim of the research. To determine the level of transforming growth factor-β (TGF-β), brain-derived neurotrophic factor (BDNF) and nerve growth factor (β-NGF) in the blood serum of patients with ischemic stroke (atherothrombotic subtype) in the acute period and over time.Materials and methods. The study involved 60 people (50% men and 50% women), who were divided into three groups of 20 people. Group I – healthy individuals; Group II – patients with hypertensive crisis without signs of target organ damage (uncomplicated hypertensive crisis); III – patients with a verified diagnosis of atherothrombotic ischemic stroke that developed against the background of a hypertensive crisis. Patients of groups I, II and III were comparable by gender, age, II and III also by comorbid background. The average age of patients was 56,3 (48,8; 63,3) years.Results. Based on the results of the study, it was found that in individuals with uncomplicated hypertensive crisis, as well as in patients with ischemic stroke, an increase in the concentration of BDNF and β-NGF in the blood serum was recorded on the first day. TGF-β1 indicators changed only in patients with ischemic stroke. In the group of patients with ischemic stroke, an increase in BDNF, β-NGF, TGF-β1 indicators was observed from the first day from the onset of the disease and persisted throughout the study period. Positive correlations were found between the concentration of BDNF and systolic and diastolic blood pressure (BP), as well as between the concentration of β-NGF and the number of points on the NIHSS scale, SBP and DBP levels.Conclusion. The registered increase in the concentration of BDNF, β-NGF in patients with hypertensive crisis may indicate the activation of microglia due to damage to the brain as a target organ, even in the absence of neurological symptoms.
- Open Access
- 20 March 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (1) , 136-143
Dynamic indices of fractalkine in ischemic stroke
Background. The problem of a personalized approach to patients with ischemic stroke does not lose its relevance. Research is being conducted aimed at searching for points of application in the pathogenesis of cerebral infarction and the possibility of influencing them in order to have a positive impact on the recovery prognosis of patients.The aim of the work. To study the level of fractalkine (FKN) in the blood serum of patients with ischemic stroke (atherothrombotic subtype) in dynamics. The data obtained in the future can serve as the basis for the possible use of fractalkine as one of the treatment options for patients with acute cerebral ischemia.Materials and methods. Sixty people took part in the study. Group I (control) – healthy people; Group II – patients with hypertensive crisis without signs of acute changes in target organs; Group III – patients with atherothrombotic pathogenetic subtype of ischemic stroke on the background of hypertensive crisis.Results. It was revealed that the level of fractalkine in patients with hypertensive crisis, and in patients on the first day after the development of ischemic stroke, was 3.2 times higher than in the control group (p < 0.001). The fractalkine content in the blood serum of patients with ischemic stroke remained high for ten days. The highest level was recorded on days 4–5 from the onset of the disease and exceeded the initial level by 27.5 % (p < 0.001). Positive correlations were established between fractalkine indicators and indicators of the NIHSS (National Institutes of Health Stroke Scale) and Rankin scales, and blood pressure (p < 0.001).Conclusion. Studying the role of fractalkine in the pathogenesis of cerebral infarction remains a promising direction. The results obtained with further research in this area may become the basis for the subsequent development of fundamentally new approaches in the treatment of patients with acute cerebral events.
- 20 March 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (1) , 136-143
Open AccessDynamic indices of fractalkine in ischemic stroke
Background. The problem of a personalized approach to patients with ischemic stroke does not lose its relevance. Research is being conducted aimed at searching for points of application in the pathogenesis of cerebral infarction and the possibility of influencing them in order to have a positive impact on the recovery prognosis of patients.The aim of the work. To study the level of fractalkine (FKN) in the blood serum of patients with ischemic stroke (atherothrombotic subtype) in dynamics. The data obtained in the future can serve as the basis for the possible use of fractalkine as one of the treatment options for patients with acute cerebral ischemia.Materials and methods. Sixty people took part in the study. Group I (control) – healthy people; Group II – patients with hypertensive crisis without signs of acute changes in target organs; Group III – patients with atherothrombotic pathogenetic subtype of ischemic stroke on the background of hypertensive crisis.Results. It was revealed that the level of fractalkine in patients with hypertensive crisis, and in patients on the first day after the development of ischemic stroke, was 3.2 times higher than in the control group (p < 0.001). The fractalkine content in the blood serum of patients with ischemic stroke remained high for ten days. The highest level was recorded on days 4–5 from the onset of the disease and exceeded the initial level by 27.5 % (p < 0.001). Positive correlations were established between fractalkine indicators and indicators of the NIHSS (National Institutes of Health Stroke Scale) and Rankin scales, and blood pressure (p < 0.001).Conclusion. Studying the role of fractalkine in the pathogenesis of cerebral infarction remains a promising direction. The results obtained with further research in this area may become the basis for the subsequent development of fundamentally new approaches in the treatment of patients with acute cerebral events.